Lv41
610 积分 2023-06-06 加入
Systemic bleeding risk assessment, inflammatory and metabolic markers: reconsidering impact of PCSK9 inhibitors on bleeding and adverse outcomes in post-PCI patients undergoing antiplatelet therapy
6小时前
求助中
Clinical pathway for the diagnosis and treatment of moderate to severe atopic dermatitis in China （2023）: an expert consensus
7天前
已完结
Phenotypes of Atopic Dermatitis and Development of Allergic Diseases
26天前
已完结
Ocular complications of atopic dermatitis
28天前
已关闭
Association between increased proteinuria induced by Bevacizumab, Ramucirumab, and Aflibercept and the risk of renal impairment and failure: a systematic review and meta-analysis
30天前
已完结
Real-world Experience with New Systemic Agents for Atopic Dermatitis in the Netherlands
1个月前
已关闭
Sotatercept and the Development of Pericardial Effusions
2个月前
已完结
International Multi-Center Case Series of Gestational Dupilumab Exposure in the Treatment of Atopic Dermatitis: Maternal Complications and Fetal Outcomes
2个月前
已完结
JAAD Game Changers: “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study”
2个月前
已完结
Long-term effectiveness and safety of dupilumab in severe asthma: A 5-year real-world multicenter study
2个月前
已完结
皖公网安备34019202002308
